October 17, 2024
2 min watch
Save
VIDEO: Bausch + Lomb prepares for Teneo trial program for transEpi PRK
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Anthony Wallace of Bausch + Lomb provides an update on the latest happenings at the company.
Wallace discussed the FDA approval of the enVista Envy IOL and the acquisition of Trukera Medical as well as plans for the Teneo excimer laser.
“We launched Teneo in the U.S. earlier this year for LASIK surgery patients with myopia with or without astigmatism,” he said. “We are now kicking off our clinical trial program to broaden those indications to include transEpi PRK.”
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Wallace reports being vice president and general manager, U.S. Surgical, Bausch + Lomb.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.